Modern approaches of radiation therapy in somatotropinomas
https://doi.org/10.22328/2079-5343-2019-10-4-66-70
Abstract
The purpose of our study is to study the current approaches of radiation therapy at somatotropinomas and to evaluate neuroimaging indices in long term periods of therapy. The object of the study was 50 patients who underwent radiotherapy. The patients were divided into 3 groups: the 1st group a 1 year after the radiation therapy 7 persons, the 2nd group 1-5 years — 19, the 3rd group 5-10 years — 24 patients. The results of determining the average daily levels of growth hormone at various times after the radiation therapy show that at the time of the first examination, all patients had active acromegaly, which was estimated by the level of growth hormone. Evaluation of the condition of patients in all groups after radiation therapy showed a decrease in growth hormone levels (p<0,01). A significant decrease was observed in group III, the average level of growth hormone was 7,8±1,2 mMe/l. The result of the dynamics of neuroimaging studies at various times after radiation therapy showed a significant decrease in the size of pituitary adenomas in all respects.
Conclusion. In the long-term period after radiation therapy, 10% of patients had a decrease in the size of the pituitary gland, 54% had normal pituitary sizes, 16% had no effect and in 20% of cases there was an empty turkish saddle. It has been established that radiation therapy, followed by medical treatment with dopamine agonists, both in the immediate and long term periods after it, contributes to the stabilization of the pathological process of acromegaly.
About the Authors
Z. Yu. KhalimovaUzbekistan
Zamira Yu. Khalimova
Tashkent
S. S. Issaeva
Uzbekistan
Saodat S. Issaeva
Tashkent
References
1. Molitvoslovova N. N. Acromegaly: current advances in the diagnosis of treatment. Probl. endocrinol., 2011, No. 1, рр. 46-57 (In Russ.).
2. Pankiv V.I. Acromegaly: pathogenesis, clinical features, diagnosis, treatment methods. International Endocrinological Journal, 2011, No. 4 (36) (In Russ.).
3. Dowsett R.J., Fowble В., Tsang R.W. et al., The treatment of acromegaly 1996.
4. Katznelson L., Atkinson J.L.D. AACE Guidelines // Endocr. Pract. 2011. C. 74-76.
5. halikova A.O. Clinical and diagnostic study of somatotropic pituitary adenomas in the conditions of the Republic of Uzbekistan. Dissertation / Ministry of Health, Research Institute of Endocrinology. Tashkent, 2007 (In Russ.).
6. Melmed S., Colao A., Barkan A., Melmed S.,Colao A., Barkan A.,Malich M., Grossman A.B., Kleinberg D., Clemmons D., Chanson P., Lavs F., Sehlechie J., Vance M.L., Ho K., Giustina A., Guidelines for Acromegaly Menegement An Update // J. Clin. Endocrinol. Metab. 2010. Vol. 94, No. 5, рр. 1509-1507.
7. Melmed S., Casanueva F.F., Klibanski A., Bronstein M.D., Chanson P., Lamberts S.W., Strasburger C.J., Wass J.A.H., Giustina A. A consensus on the diagnosis and treatment of acromegaly complications. 2012.
8. Freda Pamela U., Katznelson L., van der Lely A.J. et al. Long-acting somatostatin analog therapy of acromegaly: a meta-analysis // J. Clin. Endocrinol. Metab. 2005. Vol. 90, No. 8. Р 4465-4473.
9. Trunin Yu.K., Faller T.O. Transsphenoidal microsurgery of the pituitary adenomas. Journal. Neurosurgery issues name of N. I. Burdenko, 1989, No. 5, рр. 18-21 (In Russ.).
10. Dedov I.I., Balabolkin M.I., Marova E.I. Diseases of the organs of the endocrine system. A guide for doctors. Moscow: Izdatel’stvo Medicm, 2000, рр. 74-80 (In Russ.).
Review
For citations:
Khalimova Z.Yu., Issaeva S.S. Modern approaches of radiation therapy in somatotropinomas. Diagnostic radiology and radiotherapy. 2019;(4):66-70. (In Russ.) https://doi.org/10.22328/2079-5343-2019-10-4-66-70